Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 SonovaVarian Medical SystemsMasimoGetingeLivaNova
SymbolOTCMKTS:SONVYNYSE:VARNASDAQ:MASIOTCMKTS:GNGBYNASDAQ:LIVN
Price Information
Current Price$57.13$177.11$239.22$29.83$82.05
52 Week RangeHoldHoldBuyBuyHold
MarketRank™
Overall Score0.91.31.60.61.5
Analysis Score0.00.82.40.01.2
Community Score1.92.62.62.32.7
Dividend Score0.00.00.00.00.0
Ownership Score0.01.71.70.01.7
Earnings & Valuation Score2.51.31.30.61.9
Analyst Ratings
Consensus RecommendationHoldHoldBuyBuyHold
Consensus Price TargetN/A$159.36$272.20N/A$69.33
% Upside from Price TargetN/A-10.02% downside13.79% upsideN/A-15.50% downside
Trade Information
Market Cap$18.40 billion$16.27 billion$13.22 billion$7.58 billion$3.99 billion
Beta0.71.060.870.830.8
Average Volume22,056749,832333,4511,861500,134
Sales & Book Value
Annual Revenue$2.96 billion$3.17 billion$937.84 million$2.81 billion$1.08 billion
Price / Sales6.225.1314.102.703.68
Cashflow$2.39 per share$5.07 per share$3.37 per share$2.03 per share$7.01 per share
Price / Cash23.9334.9471.0414.6911.70
Book Value$6.35 per share$22.92 per share$21.90 per share$8.15 per share$28.59 per share
Price / Book9.007.7310.923.662.87
Profitability
Net Income$489.96 million$269.20 million$196.22 million$129.29 million$-155,180,000.00
EPS$1.49$3.91$3.22N/A$3.08
Trailing P/E Ratio38.3460.4562.1424.65N/A
Forward P/E Ratio28.0030.1263.9644.59
P/E GrowthN/AN/A3.79N/AN/A
Net MarginsN/A8.50%20.30%10.51%-21.88%
Return on Equity (ROE)N/A18.45%15.75%17.30%5.55%
Return on Assets (ROA)N/A8.08%13.12%7.90%3.07%
Dividend
Annual PayoutN/AN/AN/A$0.11N/A
Dividend YieldN/AN/AN/A0.37%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.69%N/AN/A0.50%0.47%
Current Ratio2.57%1.40%4.98%1.79%2.39%
Quick Ratio2.26%1.13%4.10%1.25%1.76%
Ownership Information
Institutional Ownership Percentage1.12%86.96%81.64%0.02%89.10%
Insider Ownership PercentageN/A0.78%11.50%N/A0.48%
Miscellaneous
Employees14,34910,0002,00010,4974,000
Shares Outstanding321.99 million91.84 million55.27 million254.15 million48.66 million
Next Earnings Date5/18/2021 (Estimated)5/3/2021 (Estimated)4/27/2021 (Estimated)4/20/2021 (Estimated)4/28/2021 (Confirmed)
OptionableNot OptionableOptionableOptionableNot OptionableOptionable
SourceHeadline
3rd Cir. Reinstates LivaNova 3T Heater-Cooler System Action - HarrisMartin Publishing3rd Cir. Reinstates LivaNova 3T Heater-Cooler System Action - HarrisMartin Publishing
harrismartin.com - April 13 at 4:12 PM
Piper Sandler Boosts LivaNova (NASDAQ:LIVN) Price Target to $92.00Piper Sandler Boosts LivaNova (NASDAQ:LIVN) Price Target to $92.00
americanbankingnews.com - April 13 at 9:16 AM
LivaNova (NASDAQ:LIVN) Given New $92.00 Price Target at Piper SandlerLivaNova (NASDAQ:LIVN) Given New $92.00 Price Target at Piper Sandler
marketbeat.com - April 13 at 7:29 AM
$232.08 Million in Sales Expected for LivaNova PLC (NASDAQ:LIVN) This Quarter$232.08 Million in Sales Expected for LivaNova PLC (NASDAQ:LIVN) This Quarter
americanbankingnews.com - April 13 at 3:16 AM
LivaNova PLC (LIVN) Stock: What Does the Chart Say Monday? - InvestorsObserverLivaNova PLC (LIVN) Stock: What Does the Chart Say Monday? - InvestorsObserver
investorsobserver.com - April 12 at 5:49 PM
Heater-Cooler suit against LivaNova revived - Mass DeviceHeater-Cooler suit against LivaNova revived - Mass Device
massdevice.com - April 12 at 12:49 PM
Zacks: Analysts Expect LivaNova PLC (NASDAQ:LIVN) to Post $0.15 Earnings Per ShareZacks: Analysts Expect LivaNova PLC (NASDAQ:LIVN) to Post $0.15 Earnings Per Share
americanbankingnews.com - April 11 at 2:12 PM
Global Ventricular Assist Device Market Expected To Reach $ 2498.37 Million Growth By 2026||Evaheart, Inc., Jarvik Heart, Inc., Medtronic, Terumo Corporation, ReliantHeart Inc., Calon Cardio, LivaNova PLC – ROUGH Magazine - ROUGH MagazineGlobal Ventricular Assist Device Market Expected To Reach $ 2498.37 Million Growth By 2026||Evaheart, Inc., Jarvik Heart, Inc., Medtronic, Terumo Corporation, ReliantHeart Inc., Calon Cardio, LivaNova PLC – ROUGH Magazine - ROUGH Magazine
rough.asia - April 9 at 7:50 PM
3rd Circ. Revives LivaNova Bacteria Exposure Suit - Law3603rd Circ. Revives LivaNova Bacteria Exposure Suit - Law360
law360.com - April 9 at 7:50 PM
LivaNova Heater-Cooler Patient Gets Infection Suit Reinstated - Bloomberg LawLivaNova Heater-Cooler Patient Gets Infection Suit Reinstated - Bloomberg Law
news.bloomberglaw.com - April 9 at 2:50 PM
Global Epilepsy Market 2021 SWOT Analysis – LivaNova, GW Pharmaceuticals, Johnson & Johnson Services, GlaxoSmithKline PLC, Pfizer, Eisai – ROUGH Magazine - ROUGH MagazineGlobal Epilepsy Market 2021 SWOT Analysis – LivaNova, GW Pharmaceuticals, Johnson & Johnson Services, GlaxoSmithKline PLC, Pfizer, Eisai – ROUGH Magazine - ROUGH Magazine
rough.asia - April 7 at 2:19 PM
Congestive Heart Failure Treatment Device Market 2021 Outlook By Micromed AS, LivaNova PLC, ABIOMED – The Market Eagle - The Market EagleCongestive Heart Failure Treatment Device Market 2021 Outlook By Micromed AS, LivaNova PLC, ABIOMED – The Market Eagle - The Market Eagle
themarketeagle.com - April 7 at 2:19 PM
Global Aortic Heart Valve Market 2021 Key Drivers – Edwards Lifesciences, Medtronic, Abbott, Livanova – ROUGH Magazine - ROUGH MagazineGlobal Aortic Heart Valve Market 2021 Key Drivers – Edwards Lifesciences, Medtronic, Abbott, Livanova – ROUGH Magazine - ROUGH Magazine
rough.asia - April 7 at 9:18 AM
Global Double Roller Pump Artificial Heart Lung Machine Market 2021 Industry Dynamics – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH MagazineGlobal Double Roller Pump Artificial Heart Lung Machine Market 2021 Industry Dynamics – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH Magazine
rough.asia - April 7 at 9:18 AM
Global Single Roller Pump Artificial Heart Lung Machine Market 2021 Key Drivers – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH MagazineGlobal Single Roller Pump Artificial Heart Lung Machine Market 2021 Key Drivers – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH Magazine
rough.asia - April 7 at 9:18 AM
Global Blood Pump-Gas Exchange System Market 2021 Key Drivers – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH MagazineGlobal Blood Pump-Gas Exchange System Market 2021 Key Drivers – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH Magazine
rough.asia - April 7 at 9:18 AM
Global Seizure Detection Devices Market Things to Focus on to Ensure Long-term Success | Medtronic PLC, - Global Banking And Finance ReviewGlobal Seizure Detection Devices Market Things to Focus on to Ensure Long-term Success | Medtronic PLC, - Global Banking And Finance Review
globalbankingandfinance.com - April 6 at 12:56 PM
Global Artificial Cardiopulmonary Machine Market 2021 SWOT Analysis – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH MagazineGlobal Artificial Cardiopulmonary Machine Market 2021 SWOT Analysis – LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group – ROUGH Magazine - ROUGH Magazine
rough.asia - April 6 at 2:56 AM
Global Percutaneous Mechanical Circulatory Support Devices Market Ongoing Analysis 2021 – Medtronic, Abbott Laboratories, LivaNova – ROUGH Magazine - ROUGH MagazineGlobal Percutaneous Mechanical Circulatory Support Devices Market Ongoing Analysis 2021 – Medtronic, Abbott Laboratories, LivaNova – ROUGH Magazine - ROUGH Magazine
rough.asia - April 5 at 4:35 PM
Global Long-term Mechanical Circulatory Support Market Ongoing Analysis 2021 – Abbott Laboratories, LivaNova, Nipro Corporation – ROUGH Magazine - ROUGH MagazineGlobal Long-term Mechanical Circulatory Support Market Ongoing Analysis 2021 – Abbott Laboratories, LivaNova, Nipro Corporation – ROUGH Magazine - ROUGH Magazine
rough.asia - April 5 at 11:35 AM
Cardiac Monitoring Devices Market New Business Experts Ideas By Biotronik, Livanova, Biotelemetry, Schiller, iRhythm Technologies - Industry TodayCardiac Monitoring Devices Market New Business Experts Ideas By Biotronik, Livanova, Biotelemetry, Schiller, iRhythm Technologies - Industry Today
industrytoday.co.uk - April 5 at 6:35 AM
Worldwide Structural Heart Device Competitive Analysis and Leadership Study 2021: Edwards Lifesciences, Medtronic, St. Jude Medical, Boston Scientific, LivaNova PLC, Abott, C.R Bard, and Cryolife - ResearchAndMarkets.com - Business WireWorldwide Structural Heart Device Competitive Analysis and Leadership Study 2021: Edwards Lifesciences, Medtronic, St. Jude Medical, Boston Scientific, LivaNova PLC, Abott, C.R Bard, and Cryolife - ResearchAndMarkets.com - Business Wire
businesswire.com - April 2 at 12:56 PM
The Chief Human Resources Officer of LivaNova is Exercising Options - Analyst RatingsThe Chief Human Resources Officer of LivaNova is Exercising Options - Analyst Ratings
analystratings.com - April 2 at 12:56 PM
Form 4 LivaNova PLC For: Mar 30 Filed by: Dolci Marco - StreetInsider.comForm 4 LivaNova PLC For: Mar 30 Filed by: Dolci Marco - StreetInsider.com
streetinsider.com - April 1 at 7:53 PM
LivaNova Reaches Analyst Target Price - NasdaqLivaNova Reaches Analyst Target Price - Nasdaq
nasdaq.com - March 29 at 1:36 PM
Stocks Generating Improved Relative Strength: Livanova - Investors Business DailyStocks Generating Improved Relative Strength: Livanova - Investor's Business Daily
investors.com - March 26 at 9:27 AM
DateCompanyBrokerageAction
3/24/2021SonovaJPMorgan Chase & Co.Reiterated Rating
2/18/2021SonovaExane BNP ParibasUpgrade
2/2/2021SonovaUBS GroupReiterated Rating
12/9/2020SonovaMorgan StanleyReiterated Rating
12/1/2020SonovaJefferies Financial GroupUpgrade
11/23/2020SonovaBerenberg BankReiterated Rating
11/17/2020SonovaCredit Suisse GroupReiterated Rating
10/8/2020SonovaCitigroupInitiated Coverage
9/29/2020SonovaDeutsche Bank AktiengesellschaftReiterated Rating
10/31/2019SonovaThe Goldman Sachs GroupDowngrade
10/28/2020Varian Medical SystemsBarrington ResearchDowngrade
10/28/2020Varian Medical SystemsRobert W. BairdDowngrade
8/10/2020Varian Medical SystemsBTIG ResearchDowngrade
8/2/2020Varian Medical SystemsPiper SandlerDowngrade
1/29/2021MasimoRaymond JamesBoost Price Target
10/28/2020MasimoStifel NicolausBoost Price Target
10/6/2020MasimoNeedham & Company LLCReiterated Rating
12/17/2019MasimoPiper Jaffray CompaniesReiterated Rating
4/13/2021GetingeDNB MarketsUpgrade
3/11/2021GetingeSEB Equity ResearchUpgrade
3/11/2021GetingeSEB EquitiesUpgrade
9/9/2020GetingeBank of AmericaInitiated Coverage
4/30/2020LivaNovaCanaccord GenuityLower Price Target
(Data available from 4/13/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.